Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Clinical trial NCT07129993 · RECRUITING

Trial details

NCT number: NCT07129993
Sponsor: Daiichi Sankyo
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Urothelial Cancer Bladder Cancer

Start date: 2025-09-26
Primary completion: 2029-06-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.